Dr. Jennifer Medlin, MD

Dr. Medlin practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Medlin's NPI, 1427491778, was assigned on April 16, 2013. Dr. Medlin graduated from University of Nebraska College of Medicine in 2013. Dr. Medlin holds Nebraska license 30815.

Dr. Medlin's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Medlin also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Medlin's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Medlin is also affiliated with Methodist Hospital. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Medlin to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medlin practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Medlin's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Medlin is licensed in Nebraska.

CMS data shows 644 Medicare services from Dr. Medlin across 6 procedure codes in 2024, for 258 Medicare patients. Medicare paid $31,244 for them.

CMS counts 258 Medicare patients who saw Dr. Medlin in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have arthritis, and 71% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Medlin's median patient age at 68, with 82% women.

In 2024, Dr. Medlin wrote 2,279 Medicare Part D claims for 386 patients. 88% of them were for generic drugs. CMS names the drug for 2,051 of them, across 39 drugs with 11 or more claims each, at $653,639 in total drug cost. In 2023, CMS named 1,548 claims across 32 drugs.

Dr. Medlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Medlin, published from 2016 to 2020. The most frequent topics are Age of Onset and Lupus Erythematosus, Systemic. Dr. Medlin has published most often in Semin Arthritis Rheum. Dr. Medlin's most frequent co-authors are Christie M. Bartels, MD, Megan R. Arthur, MD and Sara R. Fitz, MD.

CMS Open Payments shows 8 general payments to Dr. Medlin from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 78% of the total. Alexion Pharmaceuticals, Inc. paid the most, $126.

Dr. Medlin graduated from University of Nebraska College of Medicine in 2013.